Clincosm LogoSign in Get a demo

bladder cancer

Showing NaN - NaN of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Bempegaldesleukin, Radical

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Nivolumab
  • +2 more
  • Gilbert, Arizona
  • +115 more
Jan 9, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

    Completed
    Has Results
    • Prostate Cancer
    • +4 more
    • NY-ESO-1 Plasmid DNA Cancer Vaccine
    • New York, New York
    • +1 more
    Oct 3, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Bladder Cancer Trial in Houston (Prophylactic Cranial Irradiation (PCI), Brain X-ray)

    Active, not recruiting
    • Bladder Cancer
    • Prophylactic Cranial Irradiation (PCI)
    • Brain X-ray
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 18, 2022

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022

    Bladder Cancer Trial in Houston (Celecoxib, Gemcitabine, Cisplatin)

    Recruiting
    • Bladder Cancer
    • Houston, Texas
    • +1 more
    Jul 22, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Bladder Cancer, Bladder Trial in Houston (UGN-201)

    Recruiting
    • Bladder Cancer
    • Bladder
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 11, 2022

    Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution

    Active, not recruiting
    • Oncology
    • +5 more
    • MRx0518
    • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
    • Kansas City, Kansas
    • +4 more
    Jul 5, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

    Recruiting
    • Urothelial Carcinoma
    • Bladder Cancer
    • Abiraterone acetate
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 2, 2022

    Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

    Recruiting
    • Thyroid
    • +18 more
    • New Haven, Connecticut
    • +6 more
    Apr 8, 2022

    Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

    Active, not recruiting
    • Ovarian Cancer
    • +4 more
    • DPX-Survivac
    • +2 more
    • Tucson, Arizona
    • +22 more
    Mar 28, 2022

    Bladder Cancer Trial in Worldwide (Gemcitabine, E7389, Cisplatin)

    Terminated
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +41 more
    Feb 3, 2022

    Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

    Recruiting
    • Bladder Cancer
    • +9 more
    • CAdVEC
    • Houston, Texas
      Baylor St. Luke's Medical Center
    Feb 17, 2022

    Bladder Cancer Trial in Houston (Computed Tomography Urography (CTU), Intravenous Urography (IVU))

    Active, not recruiting
    • Bladder Cancer
    • Computed Tomography Urography (CTU)
    • Intravenous Urography (IVU)
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 4, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • +20 more
    • Gilbert, Arizona
    • +9 more
    Feb 3, 2022

    HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +4 more
    Feb 1, 2022